ReviewCells2026

Targeting Bruton's Tyrosine Kinase in CLL: Selectivity, Resistance Mechanisms, and Emerging Therapeutic Strategies.

Eduardo Bravo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.